-Innorna anuncia la aprobación de la FDA de IND para IN026, impulsando así las terapias basadas en ARNm para enfermedades metabólicas crónicas IN026 es una posible terapia de ARNm pionera en su clase para la gota refractaria, que marca el surgimiento de una nueva categoría de medicamentos...
Hence then, the article about innorna anuncia la aprobacion de la fda de ind para in026 was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Innorna anuncia la aprobación de la FDA de IND para IN026 )
Also on site :
- New species of sperm whale identified from fossils found in Gunma
- ‘Barry Loser’ Animated Series, Based on Bestselling U.K. Children’s Books, Finds Italian Partners Ahead of Rome’s MIA Market (EXCLUSIVE)
- Atlassian’s Mike Cannon-Brookes: AI agents need a name tag—and a human to be accountable for their mistakes